Harvard Bioscience (HBIO) Net Cash Flow Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 19.23% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -593.75% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -179.69% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 134.67% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -213.73% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 102.38% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.33% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -149.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -149.76% |
| Mar 31, 2026 | -217.47% |
| Dec 31, 2025 | 1,889.80% |
| Sep 30, 2025 | -458.94% |
| Jun 30, 2025 | 699.05% |
| Mar 31, 2025 | 793.50% |
| Dec 31, 2024 | 88.79% |
| Sep 30, 2024 | -87.52% |
| Jun 30, 2024 | -138.22% |
| Mar 31, 2024 | 115.51% |
| Dec 31, 2023 | -205.59% |
| Sep 30, 2023 | 107.19% |
| Jun 30, 2023 | 145.62% |
| Mar 31, 2023 | 66.44% |
| Dec 31, 2022 | -112.15% |
| Sep 30, 2022 | 189.43% |
| Jun 30, 2022 | -427.03% |
| Mar 31, 2022 | 1.75% |
| Dec 31, 2021 | -57.47% |
| Sep 30, 2021 | -916.25% |